News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Penn State Hershey and Serametrix to Seek Companion Diagnostic for Immunotherapy in Pediatric Cancers



4/16/2012 10:09:58 AM

SAN DIEGO--(BUSINESS WIRE)--Penn State Hershey Children’s Hospital and Serametrix will collaborate on developing a diagnostic test for predicting individual clinical response to a novel immune therapy for brain cancer, it was announced today. The serum-based test is designed to determine patient immune responses from cancer immunotherapy, enabling clinicians to determine in the future which patients may be more likely to respond to this treatment regimen.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES